Zimbabwe has rejected a major American healthcare agreement worth $367m (£272m) spanning five years over the United States' insistence on sensitive data.
This rejection was revealed following a official document from December was disclosed, which showed Head of State Emmerson Mnangagwa deemed the arrangement was "lopsided".
A government spokesperson later stated that the United States was seeking biological samples for scientific study and commercial purposes but was not willing to guarantee the benefits from future treatments.
"We will now turn to the challenging and unfortunate process of scaling back our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had provided more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has called for more dialogue to find a agreement acceptable to all parties so the nation's critical HIV programme can proceed.
Wider Background
This development follows a comparable case in Kenya, where a high court halted a related health funding agreement following legal challenges were raised about the security of Kenyans' health data.
Since returning to office recently, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
The agency had overseen aid for the American government, but Trump argued its expenditure was "wasteful" and his administration was seeking government-to-government agreements to enhance openness and responsibility.
As per reports, 16 nations in Africa have so far signed these new health pacts, representing more than $18.3bn in new funding.
Details of the Declined Agreement
This assistance for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this collaboration would have delivered significant benefits for Zimbabwean communities, particularly the 1.2 million currently on HIV treatment through American-funded initiatives," Tremont said.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unequal".
"Our nation was requested to surrender its biological resources and data for a long time, without any equivalent assurance of benefiting from any scientific breakthroughs – like new medicines or tests – that could result from that provided information," he stated.
"Put simply, our country would provide the raw materials for scientific discovery with no certainty that the resulting innovations would be available to our population if a future health crisis emerge."
National Interest and Global Health
He also pointed out that the US's withdrawal from the global health body and its push of bilateral deals were upending frameworks already set up through the international organization.
Mangwana gave as an example its Pandemic Benefit-Sharing framework designed to deal with potential pandemics.
"This framework is intended to ensure that when a country provides its data, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to create them."
The government's concerns regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We encourage ongoing dialogue with our US partners on how future collaboration might be designed in a manner that honours the sovereignty and dignity of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but recommended that negotiations should continue since much of the nation's HIV programmes depended on international support.
"In cases where specific concerns exist, including those involving data governance or implementation frameworks, these can often be addressed through technical clarification and mutually agreed protections," it commented.
The halted deal underscores the continuing challenges between accepting much-needed foreign assistance and safeguarding a country's data in an ever more data-driven world.